85
Participants
Start Date
November 13, 2017
Primary Completion Date
July 27, 2023
Study Completion Date
July 27, 2023
Denosumab
120 mg administered subcutaneously (SC) every 4 weeks (Q4W).
Royal Prince Alfred Hospital, Camperdown
Mount Sinai Beth Israel Downtown, New York
Abramson Cancer Center at Pennsylvania Hospital, Philadelphia
Washington Cancer Institute at MedStar Washington Hospital, Washington D.C.
Istituti Ortopedici Rizzoli, Bologna
University of Minnesota Medical Center Fairview, Minneapolis
Centre Leon Berard, Lyon
Sarcoma Oncology Research Center LLC, Santa Monica
Institut Gustave Roussy, Villejuif
Instytut Matki i Dziecka, Warsaw
"Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie †Panstwowy Instytut Badawczy", Warsaw
Hospital Universitari Son Espases, Palma de Mallorca
Skane Universitetssjukhus, Lund
Royal Orthopaedic Hospital, Birmingham
Lead Sponsor
Amgen
INDUSTRY